EGM
NKTR icon

Engineers Gate Manager’s Nektar Therapeutics NKTR Stock Holding History

Engineers Gate Manager’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$885K Sell
12,302
-24,982
-67% -$1.42M 0.01% 1112
2025
Q4 		$1.58M Buy
37,284
+19,654
+111% +$1.1M 0.02% 820
2025
Q3 		$1M Buy
+17,630
New +$584K 0.01% 1150
2024
Q4 		– Sell
-893
Closed -$17.4K – 2463
2024
Q3 		$17.4K Buy
+893
New +$17K ﹤0.01% 2037
2023
Q1 		– Sell
-1,374
Closed -$46.6K – 1889
2022
Q4 		$46.6K Buy
+1,374
New +$66.5K ﹤0.01% 1557
2022
Q3 		– Sell
-5,797
Closed -$330K – 1926
2022
Q2 		$330K Sell
5,797
-3,761
-39% -$237K 0.01% 1353
2022
Q1 		$773K Buy
9,558
+8,536
+835% +$1.26M 0.03% 817
2021
Q4 		$207K Buy
+1,022
New +$222K 0.01% 1638
2021
Q3 		– Sell
-8,607
Closed -$2.21M – 1859
2021
Q2 		$2.21M Buy
8,607
+6,678
+346% +$1.85M 0.14% 153
2021
Q1 		$579K Sell
1,929
-7,497
-80% -$2.33M 0.03% 902
2020
Q4 		$2.4M Buy
9,426
+7,133
+311% +$1.84M 0.1% 271
2020
Q3 		$571K Buy
2,293
+1,337
+140% +$421K 0.03% 915
2020
Q2 		$332K Sell
956
-1,646
-63% -$514K 0.02% 1169
2020
Q1 		$697K Buy
2,602
+1,455
+127% +$450K 0.05% 598
2019
Q4 		$371K Sell
1,147
-8,062
-88% -$2.34M 0.02% 1145
2019
Q3 		$2.52M Buy
9,209
+8,310
+924% +$3.05M 0.13% 241
2019
Q2 		$479K Sell
899
-230
-20% -$115K 0.03% 735
2019
Q1 		$569K Buy
+1,129
New +$669K 0.03% 584
2016
Q2 		– Sell
-2,846
Closed -$587K – 784
2016
Q1 		$587K Buy
+2,846
New +$547K 0.05% 462
2015
Q1 		– Sell
-904
Closed -$210K – 1022
2014
Q4 		$210K Buy
+904
New +$193K 0.06% 588

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Engineers Gate Manager's NKTR Position: Q1 2026 in Review

Engineers Gate Manager reduced its Nektar Therapeutics (NKTR) stake by 67% in Q1 2026, selling an estimated $1.42M and leaving 12,302 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #1112.

Engineers Gate Manager first reported a position in NKTR in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.52M in Q3 2019. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Engineers Gate Manager held 12,302 shares of Nektar Therapeutics worth $885K as of Q1 2026.
  • Engineers Gate Manager sold 24,982 Nektar Therapeutics shares in Q1 2026, an estimated $1.42M.
  • Nektar Therapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1112 holding.
  • Engineers Gate Manager first reported a position in Nektar Therapeutics in Q4 2014 and has held it in 20 quarters since.
  • Engineers Gate Manager's Nektar Therapeutics position peaked at $2.52M in Q3 2019.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.